Kathryn Yates

Kathryn Yates

Auto-generated profile, based on publicly available information

Kathryn Yates

Department of Psychiatry, Royal College of Surgeons in Ireland, Dublin 2, Ireland

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in JAMA Psychiatry
Verified
Journal Article
Open access
PDF file
KYKathryn Yates
Kathryn Yates
ULUlla Lång
Ulla Lång
MCMartin Cederlöf
Martin Cederlöf
FBFiona Boland
Fiona Boland
PTPeter Taylor
Peter Taylor
IKIan Kelleher
Ian Kelleher
There has been extensive research on psychotic experiences (PEs) in the general population over the past 2 decades. These are hallucinatory experiences and delusional beliefs that are similar to the classic positive symptoms of schizophrenia but typically associated with at least some degree of intact reality testing. Psychotic experiences are reported by 5% to 8% of the general adult population.1 While initial research focused on an increased risk for psychotic disorder in individuals who report PEs,2 much subsequent research has demonstrated that PEs are associated with high risk for a broad range of mental disorders and poor mental health outcomes in general.3-9

1 May 2022 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Closed access
ULUlla Lång
Ulla Lång
KYKathryn Yates
Kathryn Yates
FLFinbarr P. Leacy
Finbarr P. Leacy
MCMary C. Clarke
Mary C. Clarke
FMFiona McNicholas
Fiona McNicholas
IKIan Kelleher
Ian Kelleher

12 July 2021 in The British Journal of Psychiatry
Verified
Journal Article
Closed access
PDF file
KYKathryn Yates
Kathryn Yates
ULUlla Lång
Ulla Lång
EPEvyn M. Peters
Evyn M. Peters
JWJohanna T. W. Wigman
Johanna T. W. Wigman
FMFiona McNicholas
Fiona McNicholas
IKIan Kelleher
Ian Kelleher
Background: Community studies have found a relatively high prevalence of hallucinations, which are associated with a range of (psychotic and non-psychotic) mental disorders, as well as with suicidal ideation and behaviour. The literature on hallucinations in the general population has largely focused on adolescents and young adults.Aims: We aimed to explore the prevalence and psychopathologic significance of hallucinations across the adult lifespan.Method: Using the 1993, 2000, 2007 and 2014 cross-sectional Adult Psychiatric Morbidity Survey series (N = 33 637), we calculated the prevalence of past-year hallucinations in the general population ages 16 to ≥90 years. We used logistic regression to examine the relationship between hallucinations and a range of mental disorders, suicidal ideation and suicide attempts.Results: The prevalence of past-year hallucinations varied across the adult lifespan, from a high of 7% in individuals aged 16–19 years, to a low of 3% in individuals aged ≥70 years. In all age groups, hallucinations were associated with increased risk for mental disorders, suicidal ideation and suicide attempts, but there was also evidence of significant age-related variation. In particular, hallucinations in older adults were less likely to be associated with a cooccurring mental disorder, suicidal ideation or suicide attempt compared with early adulthood and middle age.Conclusions: Our findings highlight important life-course developmental features of hallucinations from early adulthood to old age.

14 December 2023 in Journal of the Royal Society of Medicine
Verified
Journal Article
Closed access
FHFlorence Halford
Florence Halford
KYKathryn Yates
Kathryn Yates
TCTom Clare
Tom Clare
JLJamie Lopez-Bernal
Jamie Lopez-Bernal
MKMeaghan Kall
Meaghan Kall
HAHester Allen
Hester Allen
Objectives: Risk of death after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has fallen during the pandemic, largely due to immunity from vaccination. In England, the timing and extent of this reduction varied due to staggered eligibility during the primary vaccination campaign, based on age and clinical risk group. Duration of protection is less well understood. Our objective was to estimate the case fatality risk (CFR) by vaccination status and time since last dose during a period of widespread community testing, to better understand the impact of coronavirus disease 2019 (COVID-19) vaccination and duration of protection. Design: SARS-CoV-2 cases diagnosed between May 2020 and February 2022 were linked to vaccine records from the National Immunisation Management System. CFR was calculated as the proportion of cases that died of COVID-19 per the death certificate, aggregated by week of specimen and stratified by 10-year age band and vaccination status. Setting: England, UK. Participants: A total of 10,616,148 SARS-CoV-2 cases, aged ≥18 years, recorded by England’s laboratory reporting system. Main outcome measures: Case fatality risk of COVID-19, stratified by age band and vaccination status. Results: Overall, a reduction in CFR was observed for all age bands, with a clear temporal link to when the age group became eligible for primary vaccination and then the first booster. CFR increased with age (0.3% 50–59 years; 1.2% 60–69; 4.7% 70–79; 16.3% 80+) and was highest in the unvaccinated – albeit a reduction was observed over time. The highest CFR was seen in the unvaccinated 80+ group prior to vaccination rollout (30.6%). CFR was consistently lowest in vaccinated populations within 6 months of last dose, yet increased after over 6 months elapsed since last dose, across all age bands. Conclusions: COVID-19 CFR reduced after vaccination, with the lowest CFR seen across all age bands when vaccinated up to 6 months prior to specimen date. This provides some evidence for continued booster doses in older age groups.

10 June 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
KYKathryn Yates
Kathryn Yates
ULUlla Lång
Ulla Lång
JDJordan DeVylder
Jordan DeVylder
MCMary Clarke
Mary Clarke
FMFiona McNicholas
Fiona McNicholas
IKIan Kelleher
Ian Kelleher

14 June 2022 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
KYKathryn Yates
Kathryn Yates
ULUlla Lång
Ulla Lång
EPEvyn M. Peters
Evyn M. Peters
JWJohanna T. W. Wigman
Johanna T. W. Wigman
DBDavid Boyda
David Boyda
IKIan Kelleher
Ian Kelleher
Background: Research has shown a strong relationship between hallucinations and suicidal behaviour in general population samples. Whether hallucinations also index suicidal behaviour risk in groups at elevated risk of suicidal behaviour, namely in individuals with a sexual assault history, remains to be seen.Aims: We assessed whether hallucinations were markers of risk for suicidal behaviour among individuals with a sexual assault history.Methods: Using the cross-sectional 2007 (N = 7403) and 2014 (N = 7546) Adult Psychiatric Morbidity Surveys, we assessed for an interaction between sexual assault and hallucinations in terms of the odds of suicide attempt, as well as directly comparing the prevalence of suicide attempt in individuals with a sexual assault history with v. without hallucinations.Results: Individuals with a sexual assault history had increased odds of hallucinations and suicide attempt compared to individuals without a sexual assault history in both samples. There was a significant interaction between sexual assault and hallucinations in terms of the odds of suicide attempt. In total, 14–19% of individuals with a sexual assault history who did not report hallucinations had one or more suicide attempt. This increased to 33–52% of individuals with a sexual assault history who did report hallucinations (2007, aOR = 2.85, 1.71–4.75; 2014, aOR = 4.52, 2.78–7.35).Conclusions: Hallucinations are a risk marker for suicide attempt even among individuals with an elevated risk of suicidal behaviour, specifically individuals with a sexual assault history. This finding highlights the clinical significance of hallucinations with regard to suicidal behaviour risk, even among high-risk populations.